Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2009 Mar 25;113(21):5206–5216. doi: 10.1182/blood-2008-09-179762

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2009 by The American Society of Hematology

PMC Copyright notice

Expression of APRIL in the FL tumor microenvironment. (A) Expression of APRIL, CD20, CD3, and CD68 was determined by immunohistochemistry in FL (n = 10). A representative case of FL, grade 1, is shown. APRIL immunoreactivity is seen within neoplastic follicles ([], top left panel) using an APRIL-specific antibody, but not an isotype control. Higher magnification (top right panel) shows the staining surrounding abnormal small lymphocytes within the neoplastic follicles. (B) Cells from normal tonsilar tissue (Ton) or FL patient specimens (n = 5) were cultured for 7 days, and supernatants were collected and assessed for APRIL by ELISA. (C) Expression of APRIL by LCL, PB mononuclear cells, CD19⁺ FL cells, and HS.5 stromal cells was determined by Western blot using APRIL-specific antibody. (D) Karpas cells were cultured alone or cocultured with irradiated HS.5 cells in the presence of TACI-Fc (5 μg/mL) or control-Fc (5 μg/mL), and growth was assessed by thymidine incorporation. Mean (± SDs) from 6 determinations obtained in 2 separate experiments are shown.

Inline graphic — Expression of APRIL in the FL tumor microenvironment. (A) Expression of APRIL, CD20, CD3, and CD68 was determined by immunohistochemistry in FL (n = 10). A representative case of FL, grade 1, is shown. APRIL immunoreactivity is seen within neoplastic follicles ([], top left panel) using an APRIL-specific antibody, but not an isotype control. Higher magnification (top right panel) shows the staining surrounding abnormal small lymphocytes within the neoplastic follicles. (B) Cells from normal tonsilar tissue (Ton) or FL patient specimens (n = 5) were cultured for 7 days, and supernatants were collected and assessed for APRIL by ELISA. (C) Expression of APRIL by LCL, PB mononuclear cells, CD19⁺ FL cells, and HS.5 stromal cells was determined by Western blot using APRIL-specific antibody. (D) Karpas cells were cultured alone or cocultured with irradiated HS.5 cells in the presence of TACI-Fc (5 μg/mL) or control-Fc (5 μg/mL), and growth was assessed by thymidine incorporation. Mean (± SDs) from 6 determinations obtained in 2 separate experiments are shown.